Sign In
Buy INSP
$40.47
-0.110 (-0.271%)
At Close: Jun 03, 2026
Inspire Medical Systems: Sleep Apnea Equipment - Today's Best Stock Buy
03:27pm, Wednesday, 26'th Oct 2022
A 3-5 month prospect from here of Inspire Medical Systems, Inc. share prices could reasonably range from a $166 low to a $210 high from its present price of $175, a +20.8% gain. 39 positions like toda
Inspire (INSP) Soars 7.9%: Is Further Upside Left in the Stock?
05:18pm, Tuesday, 18'th Oct 2022
Inspire (INSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
Inspire Medical Systems: Sleep Apnea Value Delivery Pocket
04:47am, Thursday, 13'th Oct 2022
This investment choice is based on the market's judgment that investors have favorable odds to see a +20% gain in the next few months from the stock's ownership. How do we believe that can happen? Sma
Inspire (INSP) Stock Jumps 5.6%: Will It Continue to Soar?
09:02am, Monday, 12'th Sep 2022
Inspire (INSP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Inspire Medical: Valuations Fair And Reasonable Post Q2 Earnings
11:50am, Wednesday, 03'rd Aug 2022
Inspire Medical Systems reported Q2 FY22 earnings yesterday with upside versus consensus in revenue and EPS. The company upgraded FY22 revenue guidance but narrowed its guidance on gross margin for th
Inspire Medical Systems, Inc. (INSP) CEO Tim Herbert on Q2 2022 Results - Earnings Call Transcript
10:22pm, Tuesday, 02'nd Aug 2022
Inspire Medical Systems, Inc. (NYSE:INSP ) Q2 2022 Results Conference Call August 2, 2022 5:00 PM ET Company Participants Megan Rowekamp - Investor Relations Tim Herbert - President and Chief Executiv
Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates
06:51pm, Tuesday, 02'nd Aug 2022
Inspire (INSP) delivered earnings and revenue surprises of 10.17% and 15.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Inspire Medical Systems, Inc. to Report Second Quarter 2022 Financial Results on August 2, 2022
08:00am, Tuesday, 05'th Jul 2022
MINNEAPOLIS, July 05, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2022 after the close of trading on Tuesday, Au
UPDATE — Inspire Medical Systems, Inc. to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
04:05pm, Monday, 06'th Jun 2022
MINNEAPOLIS, June 06, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative,
Inspire Medical Systems, Inc. to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
08:00am, Monday, 06'th Jun 2022
MINNEAPOLIS, June 06, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative,
Inspire Medical Systems Priced Low In Past-Year Repeated Range
01:19pm, Thursday, 12'th May 2022
Medical equipment producers suffered demand constrictions as Covid-19 hospital capacity and personnel were conscripted to handle the pandemic. INSP stock recuperated from $50 to $250 in a year. Today'
Inspire Medical Systems, Inc. to Present at the USB Global Healthcare Conference 2022
08:00am, Wednesday, 11'th May 2022
MINNEAPOLIS, May 11, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative, m
Inspire Medical Systems, Inc. (INSP) CEO Timothy Herbert on Q1 2022 Results - Earnings Call Transcript
10:26pm, Tuesday, 03'rd May 2022
Inspire Medical Systems, Inc. (NYSE:INSP ) Q1 2022 Results Conference Call May 3, 2022 5:00 PM ET Company Participants Megan Rowekamp - Investor Relations Timothy Herbert - President and Chief Executi
Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates
07:34pm, Tuesday, 03'rd May 2022
Inspire (INSP) delivered earnings and revenue surprises of 21.79% and 6.95%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
02:16pm, Wednesday, 06'th Apr 2022 Benzinga
Upgrades
According to Morgan Stanley, the prior rating for Royalty Pharma PLC (NASDAQ:RPRX) was changed from Equal-Weight to Overweight. In the fourth quarter, Royalty Pharma showed an EPS of $0.80, c
